Best Undervalued Stocks To Watch Right Now


Russ Kaplan is a leading money manager with a value-oriented and contrarian approach to very long-term investing; here’s a look at his top growth idea for the coming year.

One of the few places of value in this market is the home building stocks and our Top Pick for growth-oriented investors is D. R. Horton (DHI), which is a home building stock.

D.R. Horton is more than just a homebuilder, however. Horton is involved in all aspects of the realty area. It also owns lots of property and is into title insurance.


Yes, mortgage rates have gone up, but that is already reflected in the price of the stock, which has fallen from $38 to a recent price is the $28 range. I can see it going back to $38 in the near future.

With a price/earnings ratio of 12, it is very undervalued from the market average, which is currently around 22.

There really is a D. R. Horton and he owns 7% of the company. This is not a stock for those looking for income. It only pays a little over 1%.

Best Undervalued Stocks To Watch Right Now: Cross Timbers Royalty Trust(CRT)


Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggested shorting small cap trust stock Cross Timbers Royalty Trust (NYSE: CRT):

    On the close-up detailed chart of Cross Timber Royalty we can see how well-developed the downtrend is, but what’s so eye-catching is the way the selling volume is starting to build on the way down. The recent bearish crosses of all the key moving average lines were indeed telling of trouble.

Best Undervalued Stocks To Watch Right Now: Intrepid Potash, Inc(IPI)


Advisors’ Opinion:

  • [By Lisa Levin]

    Wednesday afternoon, basic materials shares gained by 1.74 percent. Meanwhile, top gainers in the sector included Intrepid Potash, Inc. (NYSE: IPI), and L.B. Foster Co (NASDAQ: FSTR).

  • [By Lisa Levin]

    Friday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Intrepid Potash, Inc. (NYSE: IPI) and L.B. Foster Co (NASDAQ: FSTR).

Best Undervalued Stocks To Watch Right Now: EnLink Midstream Partners, LP(ENLK)


Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    EnLink Midstream Partners (ENLK) is sponsored by independent oil and gas exploration giant Devon Energy (DVN), the owner of this acreage.

    These basins offer superior economics and EnLink’s close relationship with Devon provides leveraged exposure to the upstream operator’s accelerating activity in these plays.

Best Undervalued Stocks To Watch Right Now: Wendy’s/Arby’s Group Inc.(WEN)


Advisors’ Opinion:

  • [By Jim Jubak, Senior Markets Editor, MoneyShow.com]

    It’s hard for any company to raise prices in the current non-inflationary environment. But it’s especially hard right now for operators of fast food restaurants, given the intense price competition in a very crowded marketplace. McDonald’s sales growth in recent quarters has been driven by the success of its Dollar Menu, so raising prices in that segment are a big deal for the company. In addition, pushback from franchisees who say they can’t afford to refurbish their stores, given higher charges from McDonald’s hits at one of McDonald’s key advantages in its market—it’s ability to refresh stores more frequently than competitors. A McDonald’s refresh at $600,000 on average, according to the company, costs substantially more than a remodel at Burger King (BKW) at $300,000 or Wendy’s (WEN) at $375,000 for the least expensive version. McDonald’s restaurants average $2.5 million in annual sales.

  • [By Michael Flannelly]

    KeyBanc analysts upgraded fast food restaurant operator The Wendy’s Co (WEN) on Friday, noting that the company has a number of positive developments that could provide a floor for the stock.

    The analysts upgraded WEN from “Underweight” to “Hold.”

    KeyBanc analyst Christopher O’Cull said, “We are raising our rating for The Wendy’s Company to HOLD as we believe: 1) Wendy’s SRS performance will diverge from the industry for the foreseeable future as new products are supported by more effective use of marketing dollars; 2) better menu and promotional management will lead to improved franchisee profitability (a focus of the new CFO Todd Penegor); and 3) the opportunity to extend the re-franchising program will provide a floor on the stock.”


    Wendy’s shares were up 7 cents, or 0.81%, during pre-market trading on Friday. The stock is up 57.01% year-to-date.

  • [By Ben Levisohn]

    The market is treating Chipotle as if it is an Amazon, Tesla, Apple or Google, when in fact all they do is make burritos. With the money it would cost you to buy Chipotle today @ $14 billion dollars you could buy Wendy’s (WEN), Cheesecake Factory (CAKE), Papa John’s International (PZZA), and Dunkin’ Brands (DNKN). Chipotle would need to generate at least $24 in earnings per share in order to justify the current market cap — they are not even expected to generate half of that next year. Chipotle is expected to report Q1 on April 25 and the market, in my opinion, has already more than priced in good news.

  • [By Rich Duprey]

    And that’s despite Burger King and Wendy’s (NASDAQ:WEN) posting higher quarterly comps for years. The restaurant industry itself may be experiencing a slowdown, and fast food is falling with it after having been one of the few areas notching consistent gains, but it means McDonald’s growth was merely an aberration.

  • [By Monica Gerson]

    Analysts expect Wendys Co (NASDAQ: WEN) to report its quarterly earnings at $0.06 per share on revenue of $352.08 million. Wendys shares rose 1.79 percent to $11.38 in after-hours trading.

  • [By Ben Levisohn]

    Upgrades had a big impact on stocks today. Wendy’s (WEN), for instance, gained 4.5% to $8.62 after being upgraded to Buy at Argus, while Cash America (CSH) advanced 3.7% to $44.32 after being upgraded to Market Outperform from Market Perform at JMP Securities. Walgreen (WAG) proved the big winner in the S&P 500 afterGoldman Sachs called the stock a Conviction Buy.

Best Undervalued Stocks To Watch Right Now: Diana Shipping inc.(DSX)


Advisors’ Opinion:

  • [By Rich Smith]

    Shares of dry bulk ocean shipper Diana Shipping (NYSE:DSX) surged 37% in the first month of the new year, rising from $3.02 at the start of January to end at $4.14 at its close. As the calendar moves into February, however, Diana’s shares are moving into reverse — down more than 2% since the month began.

  • [By Lisa Levin]

    Diana Shipping Inc. (NYSE: DSX) was down, falling around 11 percent to $4.56. Diana Shipping reported an offering of $70 million in common shares.


    Commodities

  • [By Dan Caplinger]

    The stock market had a negative tone on Wednesday, although major benchmarks moved in different directions. The Dow Jones Industrials took the biggest hit, falling triple digits as one of its most influential components suffered an earnings-related drop. Relative strength in the Nasdaq Composite showed cross-currents in the overall market, but several individual stocks had substantial declines for the day, andRite Aid (NYSE:RAD), Diana Shipping (NYSE:DSX), and Finisar (NASDAQ:FNSR) were among the worst performers. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Lisa Levin]

    Diana Shipping Inc. (NYSE: DSX) shares were also up, gaining 12 percent to $5.91. JP Morgan upgraded Diana Shipping from Neutral to Overweight.

    Equities Trading DOWN

Best Undervalued Stocks To Watch Right Now: Opexa Therapeutics, Inc.(OPXA)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Opexa Therapeutics Inc (NASDAQ: OPXA) and Acer Therapeutics announced a merger that will result in 11.2-percent ownership by current Opexa shareholders and 88.8-percent ownership by current Acer shareholders.

  • [By Lisa Levin]

    Opexa Therapeutics Inc (NASDAQ: OPXA) shares were also up, gaining 66 percent to $1.08 after the company announced plans to acquire Acer Therapeutics.

  • [By Lisa Levin]

    Opexa Therapeutics Inc (NASDAQ: OPXA) shares dropped 70 percent to $1.02 after the company disclosed that its top-line results from Phase 2b Abili-T trial evaluating Tcelna did not meet primary endpoint.

Leave a Reply

Your email address will not be published. Required fields are marked *